Under construction – not a live service
Sign in
Taking people in FranceNo phase

Predictive Factors for Occlusal Changes in Obstructive Sleep Apnea Treatment With Mandibular Advancement Appliance

Key facts

Where
Toulouse, FranceSee the site

Where in France

  • University Hospital of ToulouseToulouse, FranceContact: Stéphanie BRAYERTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
University Hospital, Toulouse
Trial code
NCT06576310
Record updated
5 November 2026
Original description
This research addresses obstructive sleep apnea syndrome (OSAS), affecting 6-12% of French adults, often treated with mandibular advancement devices (MADs). MADs may lead to occlusal modifications, causing a 50% treatment abandonment rate. The study employs surface electromyography to assess masticatory muscle activity before and during MAD use, correlating it with occlusal changes after 6 months. The primary goal is to determine dental displacement profiles post-6-month MAD treatment, providing insights for personalized care and minimizing treatment failures.Read full original descriptionShow less

Evaluation of Predictive Factors for Dental Occlusal Changes in the Treatment of Obstructive Sleep Apnea With Mandibular Advancement Appliance

This research addresses obstructive sleep apnea syndrome (OSAS), affecting 6-12% of French adults, often treated with mandibular advancement devices (MADs). MADs may lead to occlusal modifications, causing a 50% treatment abandonment rate. The study employs surface electromyography to assess masticatory muscle activity before and during MAD use, correlating it with occlusal changes after 6 months. The primary goal is to determine dental displacement profiles post-6-month MAD treatment, providing insights for personalized care and minimizing treatment failures.

Inclusion: Patient with complete dentition (up to second molars); Polysomnography or polygraphy; Diagnosis of OSA; Patient receiving OAM treatment at the Odontology Department of Toulouse University Hospital; Patient with contemporary panoramic and lateral cephalometric X-rays (common practice) taken at the time of orthotic treatment; Individual affiliated with or covered by a social security scheme; Voluntary, informed, written consent, signed by both participant and investigator (prior to inclusion and any necessary research-related examinations).

Exclusion: Inability to provide informed consent; Pregnant or breastfeeding patient; Patient with curators, guardians, or legal protection.

ClinicalTrials.gov NCT06576310